Lodiperone

This classification denotes an anxiolytic with the molecular formula C21H20Cl2FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T8593BT7B4, chemically known as 5-(2-(4-(3,5-dichlorphenyl)-1-piperazinyl)ethyl)-4-(4-fluorphenyl)-4-oxazolin-2-on but generally known as lodiperone, which bears US NIH Compound Identifier 161849. European Medicines Agency schedules Lodiperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08552MIG. The term LODIPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). LODIPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lodiperone under HS 29349990 and SITC 51579. As of Q4 2014, LODIPERONE remains the US FDA Preferred Term for this commodity. Lodiperone bears US NLM identifiers UMLS ID C1881436 and NCI Concept Code C66025. SMILES: CLC1CC(N2CCN(CC2)CCC2OC(=O)[NH]C2C2CCC(F)CC2)CC(CL)C1.